314 related articles for article (PubMed ID: 35777713)
21. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
22. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
[TBL] [Abstract][Full Text] [Related]
24. Development of a five-gene signature as a novel prognostic marker in ovarian cancer.
Wang R; Ye XH; Zhao XL; Liu JL; Zhang CY
Neoplasma; 2019 May; 66(3):343-349. PubMed ID: 30569721
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
[TBL] [Abstract][Full Text] [Related]
26. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
27. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
28. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma.
Li W; Yao R; Yu N; Zhang W
Cancer Biomark; 2024; 40(1):125-139. PubMed ID: 38517778
[TBL] [Abstract][Full Text] [Related]
29. Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.
Liu J; Xu F; Cheng W; Gao L
Exp Cell Res; 2020 Oct; 395(2):112235. PubMed ID: 32805252
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
Liu C; Liu Y; Yu Y; Zhao Y; Yu A
BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
[TBL] [Abstract][Full Text] [Related]
31. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
Yang S; Ji J; Wang M; Nie J; Wang S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
[TBL] [Abstract][Full Text] [Related]
32. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
33. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
34. Development of a novel transcription factors-related prognostic signature for serous ovarian cancer.
Li H; Wu N; Liu ZY; Chen YC; Cheng Q; Wang J
Sci Rep; 2021 Mar; 11(1):7207. PubMed ID: 33785763
[TBL] [Abstract][Full Text] [Related]
35. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
[TBL] [Abstract][Full Text] [Related]
36. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.
Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y
Front Oncol; 2021; 11():686044. PubMed ID: 34422642
[TBL] [Abstract][Full Text] [Related]
37. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N
Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228
[No Abstract] [Full Text] [Related]
38. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
[TBL] [Abstract][Full Text] [Related]
39. Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer.
Liu R; Wang Y; Bu J; Li Q; Chen F; Zhu M; Chi H; Yu G; Zhu T; Zhu X; Zhao G
Int J Med Sci; 2024; 21(6):1103-1116. PubMed ID: 38774759
[No Abstract] [Full Text] [Related]
40. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal Cancer.
Shi WK; Liu YX; Qiu XY; Zhou JY; Zhou JL; Lin GL
BMC Genomics; 2022 Nov; 23(1):764. PubMed ID: 36414988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
